Recent progress in macular function self-assessment

Ophthalmic and Physiological Optics

Volumn 28, Issue 3, 2008, Pages 183-192

  Trevino, Richard ^a  

^a Evansville VA Outpatient Clinic   (United States)

Author keywords

Age related macular degeneration; Amsler grid; Computerized Amsler grid; Macular mapping test; Noise field campimetry; Preferential hyperacuity perimetry

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN;

CLINICAL TRIAL; DISEASE COURSE; DRUG INHIBITION; HUMAN; PERIMETRY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; SELF EVALUATION; SELF MONITORING; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL FIELD;

CHOROIDAL NEOVASCULARIZATION; DISEASE PROGRESSION; HUMANS; MACULAR DEGENERATION; PERIMETRY; SELF CARE; VISION TESTS;

EID: 42449094457     PISSN: 02755408     EISSN: 14751313     Source Type: Journal    
DOI: 10.1111/j.1475-1313.2008.00561.x     Document Type: Review

References (44)

1. Achard, O. A., Safran, A. B., Duret, F. C. Ragama, E. (1995) Role of the completion phenomenon in the evaluation of Amsler grid results. Am. J. Ophthalmol. 120, 322 329.
2. Adachi, M. Shirato, S. (1994) The usefulness of the noise-field test as a screening method for visual field defects. Jpn. J. Ophthalmol. 38, 392 399.
3. Almony, A., Garg, S., Peters, R. K., Mamet, R., Tsong, J., Shibuya, B., Kitridou, R. Sadun, A. A. (2005) Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy. Br. J. Ophthalmol. 89, 569 574.
4. Aulhorn, E. Köst, G. (1988) Rauschfeldkampimetrie: eine perimetrische Untersuchungsweise. Klin. Monatsbl. Augenheilkd. 192, 284 288.
5. Bartlett, H., Davies, L. Eperjesi, F. (2005) The macular mapping test: a reliability study. BMC Ophthalmol. 5, 18.
6. Brown, J. C., Kylstra, J. A. Mah, M. L. (2000) Entoptic perimetry screening for central diabetic scotomas and macular edema. Ophthalmology 107, 755 759.
7. Cheng, A. S. Vingrys, A. J. (1993) Visual losses in early age-related maculopathy. Optom. Vis. Sci. 70, 89 96.
8. Crossland, M. Rubin, G. (2007) The Amsler chart: absence of evidence is not evidence of absence. Br. J. Ophthalmol. 91, 391 393.
9. Crossland, M. D., Culham, L. E., Kabanarou, S. A. Rubin, G. S. (2005) Preferred retinal locus development in patients with macular disease. Ophthalmology 112, 1579 1585.
10. Crossland, M. D., Dakin, S. C. Bex, P. J. (2007) Illusory stimuli can be used to identify retinal blind spots. PLoS ONE 2, e1060, viewed 31 December 2007, doi :
11. Fine, A. M., Elman, M. J., Ebert, J. E., Prestia, P. A., Starr, J. S. Fine, S. L. (1986) Earliest symptoms caused by neovascular membranes in the macula. Arch. Ophthalmol. 104, 513 514.
12. Fink, W. Sadun, A. (2003) Novel 3D computerized threshold Amsler grid test, Perimetry Update 2002/2003. Kugler, Amsterdam, pp. 207 212.
13. Fink, W. Sadun, A. (2004) Three-dimensional computer-automated threshold Amsler grid test. J. Biomed. Opt. 9, 149 153.
14. Freeman, W. R., El-Brady, M. Plummer, D. J. (2004) Scanning laser entoptic perimetry for the detection of age-related macular degeneration. Arch. Ophthalmol. 122, 1647 1651.
15. Kampmeier, J., Zorn, M. M., Lang, G. K., Botros, Y. T. Lang, G. E. (2006) Vergleich des preferential-hyperacuity-perimeter (PHP)-tests mit dem Amsler-netz-test bei der diagnose verschiedener stadien der altersbezogenen makuladegeneration. Klin. Monatsbl. Augenheilkd. 223, 752 756.
16. Loewenstein, A. (2007) The significance of early detection of age-related macular degeneration. Retina 27, 873 878.
17. Loewenstein, A., Malach, R., Goldstein, M., Leibovitch, I., Barak, A., Baruch, E., Alster, Y., Rafaeli, O., Avni, I. Yassur, Y. (2003) Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology 110, 966 970.
18. Loewenstein, A., Ferencz, J. R., Lang, Y., Yeshurun, I., Pollack, A. Springer, A. (2007) 'Can We Help Patients Diagnose their CNV Early at Home? A New Home-use Macular Perimeter', Poster Presented to the Twenty-fifth Annual Meeting of the American Society of Retina Specialists. American Society of Retina Specialists, Indian Wells, CA, 4 December.
19. MacKeben, M. (2007) Macular Mapping Test. Smith-Kettlewell Eye Research Institute, San Francisco, viewed 31 December 2007. Available at: http://www.ski.org/Rehab/MacKeben/General/MMTest-webpage.html.
20. Marmor, M. F. (2000) A brief history of macular grids: from Thomas Reis to Edvard Munch and Marc Amsler. Surv. Ophthalmol. 44, 343 353.
21. Nagpal, M., Nagpal, K. Nagpal, P. N. (2007) A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis), bevacizumab (Avastin). Indian J. Ophthalmol. 55, 437 439.
22. Nazemi, P. P., Fink, W., Lim, J. I. Sadun, A. A. (2005) Scotomas of age-related macular degeneration detected and characterized by means of a novel three-dimensional computer-automated visual field test. Retina 25, 446 453.
23. Nazemi, P. P., Fink, W., Sadun, A. A., Francis, B. Minckler, D. (2007) Early detection of glaucoma by means of a novel 3D computer-automated visual field test. Br. J. Ophthalmol. 91, 1331 1336.
24. Parkes, L., Lund, J. Angelucci, A. (2001) Compulsory averaging of crowded orientation signals in human vision. Nat. Neurosci. 4, 739 744.
25. Plummer, D. J., Azen, S. P. Freeman, W. R. (2000) Scanning laser entoptic perimetry for the screening of macular and peripheral retinal disease. Arch. Ophthalmol. 118, 1205 1210.
26. Ramachandran, V. S. Gregory, R. L. (1991) Perceptual filling in of artificially induced scotomas in human vision. Nature 350, 699 702.
27. Rosner, F. (2006) Patient noncompliance: causes and solutions. Mt. Sinai J. Med. 73, 553 559.
28. Sandhu, S. S. Talks, S. J. (2005) Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br. J. Ophthalmol. 89, 967 970.
29. Schiefer, U., Skalej, M., Kolb, M., Dietrich, T. J., Kolb, R., Braun, C. Petersen, D. (1998) Lesion location influences perception of homonymous scotomata during flickering random dot pattern stimulation. Vision Res. 38, 1303 1312.
30. Schuchard, R. A. (1993) Validity and interpretation of Amsler grid reports. Arch. Ophthalmol. 111, 776 780.
31. Takeda, A. L., Colquitt, J., Clegg, A. J. Jones, J. (2007) Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Br. J. Ophthalmol. 91, 1177 1182.
32. The Macular Photocoagulation Study Group (1985) Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology 92, 603 609.
33. The Macular Photocoagulation Study Group (1994) Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch. Ophthalmol. 112, 480 488.
34. The MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419 1431.
35. The MARINA Study Group (2007a) Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch. Ophthalmol. 125, 1460 1469.
36. The MARINA Study Group (2007b) Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114, 246 252.
37. The Preferential Hyperacuity Perimeter Research Group (2005b) Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 25, 296 303.
38. The Preferential Hyperacuity Perimetry Research Group (2005a) Preferential hyperacuity perimeter for detecting choroidal neovascularization study. Ophthalmology 112, 1758 1765.
39. The Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group (2003) Verteporfin in Photodynamic Therapy study group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report No. 1. Am. J. Ophthalmol. 136, 407 418.
40. The VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805 2816.
41. The VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2005) Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 25, 815 827.
42. Trauzettel-Klosinski, S., Biermann, P., Hahn, G. Weismann, M. (2003) Assessment of parafoveal function in maculopathy: a comparison between the macular mapping test and kinetic manual perimetry. Graefes Arch. Clin. Exp. Ophthalmol. 241, 988 995.
43. Wall, M. Sadun, A. A. (1986) Threshold Amsler grid testing: cross polarizing lenses enhance yield. Arch. Ophthalmol. 104, 520 523.
44. Zaidi, F. H., Cheong-Leen, R., Gair, E. J., Weir, R., Sharkawi, E., Lee, N. Gregory-Evans, K. (2004) The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes: the West London Survey. Eye 18, 503 508.